Abstract:Cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)-stimulator of interferon genes (STING) signaling is a significant component of the innate immune system and functions as a vital sentinel mechanism to monitor cellular and tissue aberrations in microbial invasion and organ injury. cGAS, a cytosolic DNA sensor, is specialized in recognizing abnormally localized cytoplasmic double-stranded DNA (dsDNA) and catalyzes the formation of a second messenger cyclic-GMP-AMP (cGAMP), which initiates a cascade of type Ⅰ interferon and inflammatory responses mediated by STING. Micronucleus, a byproduct of chromosomal missegregation during anaphase, is also a significant contributor to cytoplasmic dsDNA. These unstable subcellular structures are susceptible to irreversible nuclear envelope rupture, exposing genomic dsDNA to the cytoplasm, which potently recruits cGAS and activates STING-mediated innate immune signaling and its downstream activities, including type Ⅰ interferon and classical nuclear factor-κB (NF-κB) signaling pathways lead to senescence, apoptosis, autophagy activating anti-cancer immunity or directly killing tumor cells. However, sustained STING activation-induced endoplasmic reticulum stress, activated chronic type Ⅰ interferon and nonclassical NF-κB signaling pathways remodel immunosuppressive tumor microenvironment, leading to immune evasion and facilitating tumor metastasis. Therefore, activated cGAS-STING signaling plays a dual role of suppressing or facilitating tumor growth in tumorigenesis and therapy. This review elaborates on research advances in mechanisms of micronucleus inducing activation of cGAS-STING signaling and its implications in tumorigenesis and therapeutic strategies of malignant tumors.

cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Cgas and Cancer Therapy: a Double-Edged Sword

The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges

Cellular functions of cGAS-STING signaling

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

cGAS-STING pathway in cancer biotherapy

Synthetic Enforcement of STING Signaling in Cancer Cells Appropriates the Immune Microenvironment for Checkpoint Inhibitor Therapy.

GAS-STING: a classical DNA recognition pathways to tumor therapy

Role of micronucleus-activated cGAS-STING signaling in antitumor immunity

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer

Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them

cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment

Epigenetic regulation of cGAS and STING expression in cancer

cGAS-STING signalling in cancer: striking a balance with chromosomal instability

The cGAS/STING signaling pathway: a cross-talk of infection, senescence and tumors